GSK
3 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CER

GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CERFor media and investors o... Read More
GSK
3 years ago ⋅ English ⋅ 15 min read
Newsroom
ViiV Healthcare to present new long-term findings from its innovative 2-drug and long-acting HIV medicines portfolio at CROI 2022

For media and investors onlyData reinforce ViiV Healthcare’s leadership and commitment to developing ground-breaking medicines for HIV treatment and preventionViiV Healthcare, the... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK announces settlement between ViiV Healthcare and Gilead Sciences, Inc. resolving litigation relating to Biktarvy and ViiV’s dolutegravir patents and entry into a patent licence agreement

For media and investors only- Gilead will make an upfront payment of $1.25 billion to ViiV Healthcare in the first quarter of 2022- Gilead will also pay a 3% royalty on future US sales... Read More
GSK
3 years ago ⋅ English ⋅ 9 min read
Newsroom
ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment

For media and investors onlyCabenuva is now approved for administration as few as six times a year for virologically suppressed adults living with HIV without prior treatment failure or... Read More
GSK
3 years ago ⋅ English ⋅ 7 min read
Newsroom
Tony Wood appointed Chief Scientific Officer designate, GSK

For media and investors only- Tony Wood to assume full accountability for GSK R&D in August 2022- Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director wi... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
Update - GSK Consumer Healthcare

For media and investors onlyGlaxoSmithKline (GSK) plc today confirms that it has received three unsolicited, conditional and non-binding proposals from Unilever plc to acquire the GSK C... Read More